Literature DB >> 8231333

Do patients' evaluations of a future health state change when they actually enter that state?

H A Llewellyn-Thomas1, H J Sutherland, E C Thiel.   

Abstract

Fundamental to using utilities for future health states for clinical decision analysis is the assumption that the utilities are stable. The purpose of this study was to determine if cancer patients' prior evaluations of a treatment-induced health state remain stable when they later experience that state. Before a four-week course of radiation therapy, 66 laryngeal cancer patients evaluated three common treatment-induced outcome scenarios (mild/moderate/severe) using rating scales and the time trade-off, and provided self-assessments of voice symptoms, voice function, and general health. Evaluations and self-assessments were repeated at the end of therapy, and respondents indicated which outcome scenario described their actual end-of-therapy state. Twenty-four patients identified the mild scenario as their outcome state, 36 the moderate, and 6 the severe. No across-time differences in evaluations were detected, although significant (P < .0001) downward shifts in scores for voice symptoms (t = 5.67), voice function (t = 5.10), and general health (t = 6.69) indicated that actual change in health status had occurred. These results imply that patients' evaluations of imagined short-term health states encountered during radiation therapy for laryngeal cancer remain consistent when those states are experienced at a later time. The design of this project provides a model for determining if this consistency appears in other clinical situations.

Entities:  

Mesh:

Year:  1993        PMID: 8231333     DOI: 10.1097/00005650-199311000-00003

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  22 in total

1.  The stability of utility scores: test-retest reliability and the interpretation of utility scores in elective total hip arthroplasty.

Authors:  D Feeny; C M Blanchard; J L Mahon; R Bourne; C Rorabeck; L Stitt; S Webster-Bogaert
Journal:  Qual Life Res       Date:  2004-02       Impact factor: 4.147

2.  Chained time trade-off and standard gamble methods. Applications in oesophageal cancer.

Authors:  Paul McNamee; Sharon Glendinning; Jonathan Shenfine; Nick Steen; S Michael Griffin; John Bond
Journal:  Eur J Health Econ       Date:  2004-02

3.  Canadian guidelines for economic evaluation of pharmaceuticals. Canadian Collaborative Workshop for Pharmacoeconomics.

Authors:  G W Torrance; D Blaker; A Detsky; W Kennedy; F Schubert; D Menon; P Tugwell; R Konchak; E Hubbard; T Firestone
Journal:  Pharmacoeconomics       Date:  1996-06       Impact factor: 4.981

4.  The effect of assessment method and respondent population on utilities elicited for Gaucher disease.

Authors:  A E Clarke; M K Goldstein; D Michelson; A M Garber; L A Lenert
Journal:  Qual Life Res       Date:  1997-03       Impact factor: 4.147

5.  Health state valuations from the general public using the visual analogue scale.

Authors:  C Gudex; P Dolan; P Kind; A Williams
Journal:  Qual Life Res       Date:  1996-12       Impact factor: 4.147

Review 6.  Quality of life measures in cancer chemotherapy: methodology and implications.

Authors:  P A Ganz
Journal:  Pharmacoeconomics       Date:  1994-05       Impact factor: 4.981

Review 7.  Patient autonomy in emergency medicine.

Authors:  A C Naess; R Foerde; P A Steen
Journal:  Med Health Care Philos       Date:  2001

8.  Using health-related quality-of-life information: clinical encounters, clinical trials, and health policy.

Authors:  J Tsevat; J C Weeks; E Guadagnoli; A N Tosteson; C M Mangione; J S Pliskin; M C Weinstein; P D Cleary
Journal:  J Gen Intern Med       Date:  1994-10       Impact factor: 5.128

9.  Opinion polling and decision making: a critical appraisal of quality of life assessment.

Authors:  H J Sutherland; J E Till
Journal:  Qual Life Res       Date:  1994-04       Impact factor: 4.147

10.  Eliciting utilities using functional methodology: people's disutilities for the adverse outcomes of cardiopulmonary resuscitation.

Authors:  Alexandra Gamelin; María Teresa Muñoz Sastre; Paul Clay Sorum; Etienne Mullet
Journal:  Qual Life Res       Date:  2006-04       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.